Iowa State Bank’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,750
| Closed | -$25K | – | 126 |
|
|
2020
Q3 | $25K | Hold |
2,750
| – | – | 0.01% | 118 |
|
|
2020
Q2 | $13K | Hold |
2,750
| – | – | 0.01% | 109 |
|
|
2020
Q1 | $10K | Hold |
2,750
| – | – | ﹤0.01% | 120 |
|
|
2019
Q4 | $17K | Sell |
2,750
-11
| -0.4% | -$87 | 0.01% | 134 |
|
|
2019
Q3 | $30K | Hold |
2,761
| – | – | 0.01% | 129 |
|
|
2019
Q2 | $77K | Buy |
2,761
+1,313
| +91% | +$33K | 0.03% | 104 |
|
|
2019
Q1 | $39K | Buy |
1,448
+187
| +15% | +$6.88K | 0.02% | 102 |
|
|
2018
Q4 | $36K | Hold |
1,261
| – | – | 0.02% | 100 |
|
|
2018
Q3 | $97K | Hold |
1,261
| – | – | 0.04% | 100 |
|
|
2018
Q2 | $131K | Hold |
1,261
| – | – | 0.06% | 101 |
|
|
2018
Q1 | $159K | Hold |
1,261
| – | – | 0.08% | 97 |
|
|
2017
Q4 | $82K | Sell |
1,261
-250
| -17% | -$15.1K | 0.04% | 95 |
|
|
2017
Q3 | $89K | Hold |
1,511
| – | – | 0.04% | 93 |
|
|
2017
Q2 | $97K | Hold |
1,511
| – | – | 0.05% | 95 |
|
|
2017
Q1 | $118K | Hold |
1,511
| – | – | 0.06% | 89 |
|
|
2016
Q4 | $71K | Buy |
1,511
+250
| +20% | +$15.3K | 0.04% | 84 |
|
|
2016
Q3 | $91K | Hold |
1,261
| – | – | 0.05% | 88 |
|
|
2016
Q2 | $80K | Buy |
1,261
+72
| +6% | +$11.8K | 0.04% | 91 |
|
|
2016
Q1 | $276K | Hold |
1,189
| – | – | 0.16% | 75 |
|
|
2015
Q4 | $378K | Buy |
+1,189
| New | +$323K | 0.22% | 62 |
|
Other funds holding ZVRA
Iowa State Bank's ZVRA Position: Q4 2020 in Review
Iowa State Bank sold out of Zevra Therapeutics (ZVRA) in Q4 2020, closing a stake of 2,750 shares — an estimated $25K sold.
Iowa State Bank first reported a position in ZVRA in Q4 2015 and held it in 20 quarters. The position peaked at $378K in Q4 2015. 2 funds tracked by Wall St. Rank hold ZVRA as of Q4 2020.
- Iowa State Bank reported no remaining Zevra Therapeutics position as of Q4 2020 after selling out during the quarter.
- Iowa State Bank sold 2,750 Zevra Therapeutics shares in Q4 2020, an estimated $25K.
- Iowa State Bank first reported a position in Zevra Therapeutics in Q4 2015 and held it in 20 quarters.
- Iowa State Bank's Zevra Therapeutics position peaked at $378K in Q4 2015.
- 2 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2020.
Based on Iowa State Bank's 13F filing for Q4 2020, filed 4 Feb 2021.